FDA Issues New Guidance on 21 CFR 211.11
The FDA has issued new guidance on “Considerations for Complying With 21 CFR 211.110.” According
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
